English

T2 BIOSYSTEMS, INC.

EDGAR

TTOO Quarterly report (10-Q) · filed 2024-11-14

80 filing records in this dataset, filed from 2014-07-02 to 2024-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.99 million USD

2024 Q3 · USD

Exact inputs and evidence

Revenue: 1985000 USD Source

Operating margin

-511.89%

2024 Q3 · %

Exact inputs and evidence

Operating Income: -10161000 USD Source
Revenue: 1985000 USD Source

Operating cash flow

-6.25 million USD

2024 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -27176000 USD Source
Operating Cash Flow: -20924000 USD Source

Cash and cash equivalents: 2.08 million USD 2024-09-30 Source
Exact value

2083000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 18.8 million shares 2024-09-30 Source
Exact value

18760092 shares

Reported share-count change

378.76% · 14.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

3918438 shares · 2023-09-30· Source
18760092 shares · 2024-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-14.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2023-12-31
Operating income: 9 of 11 periods available· newest 2023-12-31
Net income: 9 of 11 periods available· newest 2023-12-31
Operating cash flow: 9 of 11 periods available· newest 2023-12-31
Capital expenditure: 9 of 11 periods available· newest 2023-12-31
Total assets: 8 of 11 periods available· newest 2023-12-31
Total liabilities: 3 of 11 periods available· newest 2023-12-31
Current assets: 8 of 11 periods available· newest 2023-12-31
Current liabilities: 8 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-67.8%

Prior period

USD 22.31 million

2022-01-01 – 2022-12-31
Current period

USD 7.19 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

7193000 − 22305000 = -15112000 USD

22305000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
7193000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Year-over-year change in Revenue: -15112000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7193000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1967610 Filing: 000095017024039310 Input fundies:Revenue: 22305000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1968965 Filing: 000095017024039310
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 11.93 million

Prior period

−USD 62 million

2022-01-01 – 2022-12-31
Current period

−USD 50.08 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-50077000 − -62003000 = 11926000 USD

-62003000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-50077000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Year-over-year change in Net income: 11926000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -50077000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1604254 Filing: 000095017024039310 Input fundies:NetIncome: -62003000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1448615 Filing: 000095017024039310
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.49 million

Prior period

−USD 50.63 million

2022-01-01 – 2022-12-31
Current period

−USD 48.14 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-48136000 − -50629000 = 2493000 USD

-50629000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-48136000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Year-over-year change in Operating cash flow: 2493000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -48136000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1683400 Filing: 000095017024039310 Input fundies:OperatingCashFlow: -50629000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1684705 Filing: 000095017024039310
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-43.4%

Prior period

USD 339,000

2022-01-01 – 2022-12-31
Current period

USD 192,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

192000 − 339000 = -147000 USD

339000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
192000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Year-over-year change in Capital expenditure: -147000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 192000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1690899 Filing: 000095017024039310 Input fundies:CapitalExpenditure: 339000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1692296 Filing: 000095017024039310
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 7.19 million 100% of revenue
Operating costs Derived USD 56.86 million 790% of revenue
Operating income −USD 49.66 million −690% of revenue
Tax, interest and other Derived USD 413,000 5.7% of revenue
Net income −USD 50.08 million −696% of revenue

Cash

Operating cash flow −USD 48.14 million −669% of revenue
Capital expenditure USD 192,000 2.7% of revenue
Free cash flow Derived −USD 48.33 million −672% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 1,642% of revenue.
2016 Operating loss: operating costs were 1,347% of revenue.
2017 Operating loss: operating costs were 1,254% of revenue.
2018 Operating loss: operating costs were 529% of revenue.
2019 Operating loss: operating costs were 725% of revenue.
2020 Operating loss: operating costs were 328% of revenue.
2021 Operating loss: operating costs were 253% of revenue.
2022 Operating loss: operating costs were 347% of revenue.
2023 Operating loss: operating costs were 790% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	2813000	46196000 Derived	-43383000	1907000 Derived	-45290000	-45439000 Derived	Source 2015-01-01 – 2015-12-31: 2813000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -43383000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -45290000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -37465000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 7974000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	4080000	54958000 Derived	-50878000	3926000 Derived	-54804000	-51929000 Derived	Source 2016-01-01 – 2016-12-31: 4080000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -50878000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -54804000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -46442000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 5487000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	4666000	58518000 Derived	-53852000	8576000 Derived	-62428000	-50194000 Derived	Source 2017-01-01 – 2017-12-31: 4666000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -53852000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -62428000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -47718000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2476000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	10500000	55590000 Derived	-45090000	6063000 Derived	-51153000	-40731000 Derived	Source 2018-01-01 – 2018-12-31: 10500000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -45090000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -51153000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -40138000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 593000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	8335000	60393000 Derived	-52058000	6948000 Derived	-59006000	-46122000 Derived	Source 2019-01-01 – 2019-12-31: 8335000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -52058000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -59006000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -45361000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 761000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	18130000	59486000 Derived	-41356000	5442000 Derived	-46798000	-44019000 Derived	Source 2020-01-01 – 2020-12-31: 18130000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -41356000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -46798000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -43215000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 804000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	28058000	71031000 Derived	-42973000	6268000 Derived	-49241000	-39334000 Derived	Source 2021-01-01 – 2021-12-31: 28058000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -42973000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -49241000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -38874000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 460000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	22305000	77501000 Derived	-55196000	6807000 Derived	-62003000	-50968000 Derived	Source 2022-01-01 – 2022-12-31: 22305000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -55196000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -62003000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -50629000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 339000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	7193000	56857000 Derived	-49664000	413000 Derived	-50077000	-48328000 Derived	Source 2023-01-01 – 2023-12-31: 7193000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -49664000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -50077000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -48136000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 192000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.2M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	2813000	Revenue: 2813000 Open source
20162016-12-31	Revenue	4080000	Revenue: 4080000 Open source
20172017-12-31	Revenue	4666000	Revenue: 4666000 Open source
20182018-12-31	Revenue	10500000	Revenue: 10500000 Open source
20192019-12-31	Revenue	8335000	Revenue: 8335000 Open source
20202020-12-31	Revenue	18130000	Revenue: 18130000 Open source
20212021-12-31	Revenue	28058000	Revenue: 28058000 Open source
20222022-12-31	Revenue	22305000	Revenue: 22305000 Open source
20232023-12-31	Revenue	7193000	Revenue: 7193000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-67.8% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 2813000 Open source
20162016-12-31	Year over year	45%	Revenue: 4080000 Open source Revenue: 2813000 Open source
20172017-12-31	Year over year	14.4%	Revenue: 4666000 Open source Revenue: 4080000 Open source
20182018-12-31	Year over year	125%	Revenue: 10500000 Open source Revenue: 4666000 Open source
20192019-12-31	Year over year	-20.6%	Revenue: 8335000 Open source Revenue: 10500000 Open source
20202020-12-31	Year over year	117.5%	Revenue: 18130000 Open source Revenue: 8335000 Open source
20212021-12-31	Year over year	54.8%	Revenue: 28058000 Open source Revenue: 18130000 Open source
20222022-12-31	Year over year	-20.5%	Revenue: 22305000 Open source Revenue: 28058000 Open source
20232023-12-31	Year over year	-67.8%	Revenue: 7193000 Open source Revenue: 22305000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -690.4% 2023

Net margin -696.2% 2023

Free cash flow margin -671.9% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-1,542.2%	Operating Income: -43383000 Open source Revenue: 2813000 Open source
20162016-12-31	Operating margin	-1,247%	Operating Income: -50878000 Open source Revenue: 4080000 Open source
20172017-12-31	Operating margin	-1,154.1%	Operating Income: -53852000 Open source Revenue: 4666000 Open source
20182018-12-31	Operating margin	-429.4%	Operating Income: -45090000 Open source Revenue: 10500000 Open source
20192019-12-31	Operating margin	-624.6%	Operating Income: -52058000 Open source Revenue: 8335000 Open source
20202020-12-31	Operating margin	-228.1%	Operating Income: -41356000 Open source Revenue: 18130000 Open source
20212021-12-31	Operating margin	-153.2%	Operating Income: -42973000 Open source Revenue: 28058000 Open source
20222022-12-31	Operating margin	-247.5%	Operating Income: -55196000 Open source Revenue: 22305000 Open source
20232023-12-31	Operating margin	-690.4%	Operating Income: -49664000 Open source Revenue: 7193000 Open source
20152015-12-31	Net margin	-1,610%	Net Income: -45290000 Open source Revenue: 2813000 Open source
20162016-12-31	Net margin	-1,343.2%	Net Income: -54804000 Open source Revenue: 4080000 Open source
20172017-12-31	Net margin	-1,337.9%	Net Income: -62428000 Open source Revenue: 4666000 Open source
20182018-12-31	Net margin	-487.2%	Net Income: -51153000 Open source Revenue: 10500000 Open source
20192019-12-31	Net margin	-707.9%	Net Income: -59006000 Open source Revenue: 8335000 Open source
20202020-12-31	Net margin	-258.1%	Net Income: -46798000 Open source Revenue: 18130000 Open source
20212021-12-31	Net margin	-175.5%	Net Income: -49241000 Open source Revenue: 28058000 Open source
20222022-12-31	Net margin	-278%	Net Income: -62003000 Open source Revenue: 22305000 Open source
20232023-12-31	Net margin	-696.2%	Net Income: -50077000 Open source Revenue: 7193000 Open source
20152015-12-31	Free cash flow margin	-1,615.3%	Revenue: 2813000 Open source Operating Cash Flow: -37465000 Open source Capital Expenditure: 7974000 Open source
20162016-12-31	Free cash flow margin	-1,272.8%	Revenue: 4080000 Open source Operating Cash Flow: -46442000 Open source Capital Expenditure: 5487000 Open source
20172017-12-31	Free cash flow margin	-1,075.7%	Revenue: 4666000 Open source Operating Cash Flow: -47718000 Open source Capital Expenditure: 2476000 Open source
20182018-12-31	Free cash flow margin	-387.9%	Revenue: 10500000 Open source Operating Cash Flow: -40138000 Open source Capital Expenditure: 593000 Open source
20192019-12-31	Free cash flow margin	-553.4%	Revenue: 8335000 Open source Operating Cash Flow: -45361000 Open source Capital Expenditure: 761000 Open source
20202020-12-31	Free cash flow margin	-242.8%	Revenue: 18130000 Open source Operating Cash Flow: -43215000 Open source Capital Expenditure: 804000 Open source
20212021-12-31	Free cash flow margin	-140.2%	Revenue: 28058000 Open source Operating Cash Flow: -38874000 Open source Capital Expenditure: 460000 Open source
20222022-12-31	Free cash flow margin	-228.5%	Revenue: 22305000 Open source Operating Cash Flow: -50629000 Open source Capital Expenditure: 339000 Open source
20232023-12-31	Free cash flow margin	-671.9%	Revenue: 7193000 Open source Operating Cash Flow: -48136000 Open source Capital Expenditure: 192000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -48.1M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-37465000	Operating Cash Flow: -37465000 Open source
20162016-12-31	Operating cash flow	-46442000	Operating Cash Flow: -46442000 Open source
20172017-12-31	Operating cash flow	-47718000	Operating Cash Flow: -47718000 Open source
20182018-12-31	Operating cash flow	-40138000	Operating Cash Flow: -40138000 Open source
20192019-12-31	Operating cash flow	-45361000	Operating Cash Flow: -45361000 Open source
20202020-12-31	Operating cash flow	-43215000	Operating Cash Flow: -43215000 Open source
20212021-12-31	Operating cash flow	-38874000	Operating Cash Flow: -38874000 Open source
20222022-12-31	Operating cash flow	-50629000	Operating Cash Flow: -50629000 Open source
20232023-12-31	Operating cash flow	-48136000	Operating Cash Flow: -48136000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -48.3M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-45439000	Operating Cash Flow: -37465000 Open source Capital Expenditure: 7974000 Open source
20162016-12-31	Free cash flow	-51929000	Operating Cash Flow: -46442000 Open source Capital Expenditure: 5487000 Open source
20172017-12-31	Free cash flow	-50194000	Operating Cash Flow: -47718000 Open source Capital Expenditure: 2476000 Open source
20182018-12-31	Free cash flow	-40731000	Operating Cash Flow: -40138000 Open source Capital Expenditure: 593000 Open source
20192019-12-31	Free cash flow	-46122000	Operating Cash Flow: -45361000 Open source Capital Expenditure: 761000 Open source
20202020-12-31	Free cash flow	-44019000	Operating Cash Flow: -43215000 Open source Capital Expenditure: 804000 Open source
20212021-12-31	Free cash flow	-39334000	Operating Cash Flow: -38874000 Open source Capital Expenditure: 460000 Open source
20222022-12-31	Free cash flow	-50968000	Operating Cash Flow: -50629000 Open source Capital Expenditure: 339000 Open source
20232023-12-31	Free cash flow	-48328000	Operating Cash Flow: -48136000 Open source Capital Expenditure: 192000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

180.6% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
2016-12-31	Liabilities / assets	Not reported	Total Assets: 89568000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 54861000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 64309000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 28486000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 79078000 Open source
20212021-12-31	Liabilities / assets	121.3%	Total Liabilities: 73442000 Open source Total Assets: 60539000 Open source
20222022-12-31	Liabilities / assets	215.5%	Total Liabilities: 73982000 Open source Total Assets: 34327000 Open source
20232023-12-31	Liabilities / assets	180.6%	Total Liabilities: 62833000 Open source Total Assets: 34797000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.45× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	7.63×	Current Assets: 75438000 Open source Current Liabilities: 9885000 Open source
20172017-12-31	Current assets / current liabilities	0.86×	Current Assets: 44318000 Open source Current Liabilities: 51782000 Open source
20182018-12-31	Current assets / current liabilities	1.08×	Current Assets: 56608000 Open source Current Liabilities: 52297000 Open source
20192019-12-31	Current assets / current liabilities	0.31×	Current Assets: 18895000 Open source Current Liabilities: 60572000 Open source
20202020-12-31	Current assets / current liabilities	5.47×	Current Assets: 53584000 Open source Current Liabilities: 9800000 Open source
20212021-12-31	Current assets / current liabilities	3.8×	Current Assets: 44394000 Open source Current Liabilities: 11688000 Open source
20222022-12-31	Current assets / current liabilities	1.91×	Current Assets: 19359000 Open source Current Liabilities: 10128000 Open source
20232023-12-31	Current assets / current liabilities	0.45×	Current Assets: 25189000 Open source Current Liabilities: 56152000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 45.29 million Exact value Exact value: -45290000 USD 2015-01-01 – 2015-12-31: -45290000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2015-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -45290000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45290000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459018006225/ttoo-20171231.xml#129697 Filing: 000156459018006225 The citation records this snapshot. The page link may show a newer release later.	−USD 37.47 million Exact value Exact value: -37465000 USD 2015-01-01 – 2015-12-31: -37465000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2015-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -37465000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37465000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459018006225/ttoo-20171231.xml#151934 Filing: 000156459018006225 The citation records this snapshot. The page link may show a newer release later.	USD 7.97 million Exact value Exact value: 7974000 USD 2015-01-01 – 2015-12-31: 7974000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2015-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 7974000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7974000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459018006225/ttoo-20171231.xml#152566 Filing: 000156459018006225 The citation records this snapshot. The page link may show a newer release later.	−USD 45.44 million Calculation and evidence -37465000 − 7974000 USD Exact free cash flow: -45439000 USD 2015-01-01 – 2015-12-31: -37465000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 7974000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2015-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -45439000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37465000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459018006225/ttoo-20171231.xml#151934 Filing: 000156459018006225 Input fundies:CapitalExpenditure: 7974000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459018006225/ttoo-20171231.xml#152566 Filing: 000156459018006225 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 54.8 million Exact value Exact value: -54804000 USD 2016-01-01 – 2016-12-31: -54804000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2016-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -54804000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54804000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/ttoo-20181231.xml#175360 Filing: 000156459019007862 The citation records this snapshot. The page link may show a newer release later.	−USD 46.44 million Exact value Exact value: -46442000 USD 2016-01-01 – 2016-12-31: -46442000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2016-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -46442000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46442000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/ttoo-20181231.xml#199467 Filing: 000156459019007862 The citation records this snapshot. The page link may show a newer release later.	USD 5.49 million Exact value Exact value: 5487000 USD 2016-01-01 – 2016-12-31: 5487000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2016-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 5487000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5487000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/ttoo-20181231.xml#200098 Filing: 000156459019007862 The citation records this snapshot. The page link may show a newer release later.	−USD 51.93 million Calculation and evidence -46442000 − 5487000 USD Exact free cash flow: -51929000 USD 2016-01-01 – 2016-12-31: -46442000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 5487000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2016-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -51929000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46442000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/ttoo-20181231.xml#199467 Filing: 000156459019007862 Input fundies:CapitalExpenditure: 5487000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/ttoo-20181231.xml#200098 Filing: 000156459019007862 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 62.43 million Exact value Exact value: -62428000 USD 2017-01-01 – 2017-12-31: -62428000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2017-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -62428000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62428000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#232411 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	−USD 47.72 million Exact value Exact value: -47718000 USD 2017-01-01 – 2017-12-31: -47718000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2017-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -47718000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47718000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#257838 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	USD 2.48 million Exact value Exact value: 2476000 USD 2017-01-01 – 2017-12-31: 2476000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2017-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 2476000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2476000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#258468 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	−USD 50.19 million Calculation and evidence -47718000 − 2476000 USD Exact free cash flow: -50194000 USD 2017-01-01 – 2017-12-31: -47718000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2476000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2017-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -50194000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47718000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#257838 Filing: 000156459020011217 Input fundies:CapitalExpenditure: 2476000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#258468 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 51.15 million Exact value Exact value: -51153000 USD 2018-01-01 – 2018-12-31: -51153000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2018-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -51153000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51153000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#232257 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	−USD 40.14 million Exact value Exact value: -40138000 USD 2018-01-01 – 2018-12-31: -40138000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2018-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -40138000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40138000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#257626 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	USD 593,000 Exact value Exact value: 593000 USD 2018-01-01 – 2018-12-31: 593000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2018-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 593000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 593000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#258259 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.	−USD 40.73 million Calculation and evidence -40138000 − 593000 USD Exact free cash flow: -40731000 USD 2018-01-01 – 2018-12-31: -40138000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 593000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2018-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -40731000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40138000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#257626 Filing: 000156459020011217 Input fundies:CapitalExpenditure: 593000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/ttoo-20191231.xml#258259 Filing: 000156459020011217 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 59.01 million Exact value Exact value: -59006000 USD 2019-01-01 – 2019-12-31: -59006000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2019-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -59006000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59006000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459021017074/ttoo-10k_20201231.htm#3496244 Filing: 000156459021017074 The citation records this snapshot. The page link may show a newer release later.	−USD 45.36 million Exact value Exact value: -45361000 USD 2019-01-01 – 2019-12-31: -45361000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2019-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -45361000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45361000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459021017074/ttoo-10k_20201231.htm#2507547 Filing: 000156459021017074 The citation records this snapshot. The page link may show a newer release later.	USD 761,000 Exact value Exact value: 761000 USD 2019-01-01 – 2019-12-31: 761000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2019-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 761000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 761000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459021017074/ttoo-10k_20201231.htm#2526518 Filing: 000156459021017074 The citation records this snapshot. The page link may show a newer release later.	−USD 46.12 million Calculation and evidence -45361000 − 761000 USD Exact free cash flow: -46122000 USD 2019-01-01 – 2019-12-31: -45361000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 761000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2019-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -46122000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45361000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459021017074/ttoo-10k_20201231.htm#2507547 Filing: 000156459021017074 Input fundies:CapitalExpenditure: 761000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459021017074/ttoo-10k_20201231.htm#2526518 Filing: 000156459021017074 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 46.8 million Exact value Exact value: -46798000 USD 2020-01-01 – 2020-12-31: -46798000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2020-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -46798000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46798000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459022011526/ttoo-10k_20211231.htm#2866606 Filing: 000156459022011526 The citation records this snapshot. The page link may show a newer release later.	−USD 43.22 million Exact value Exact value: -43215000 USD 2020-01-01 – 2020-12-31: -43215000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2020-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -43215000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43215000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459022011526/ttoo-10k_20211231.htm#1898871 Filing: 000156459022011526 The citation records this snapshot. The page link may show a newer release later.	USD 804,000 Exact value Exact value: 804000 USD 2020-01-01 – 2020-12-31: 804000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2020-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 804000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 804000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459022011526/ttoo-10k_20211231.htm#1918066 Filing: 000156459022011526 The citation records this snapshot. The page link may show a newer release later.	−USD 44.02 million Calculation and evidence -43215000 − 804000 USD Exact free cash flow: -44019000 USD 2020-01-01 – 2020-12-31: -43215000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 804000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2020-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -44019000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43215000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459022011526/ttoo-10k_20211231.htm#1898871 Filing: 000156459022011526 Input fundies:CapitalExpenditure: 804000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000156459022011526/ttoo-10k_20211231.htm#1918066 Filing: 000156459022011526 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 49.24 million Exact value Exact value: -49241000 USD 2021-01-01 – 2021-12-31: -49241000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2021-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -49241000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -49241000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017023011396/ttoo-20221231.htm#1839489 Filing: 000095017023011396 The citation records this snapshot. The page link may show a newer release later.	−USD 38.87 million Exact value Exact value: -38874000 USD 2021-01-01 – 2021-12-31: -38874000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2021-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -38874000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38874000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017023011396/ttoo-20221231.htm#2153441 Filing: 000095017023011396 The citation records this snapshot. The page link may show a newer release later.	USD 460,000 Exact value Exact value: 460000 USD 2021-01-01 – 2021-12-31: 460000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2021-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 460000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 460000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017023011396/ttoo-20221231.htm#2169735 Filing: 000095017023011396 The citation records this snapshot. The page link may show a newer release later.	−USD 39.33 million Calculation and evidence -38874000 − 460000 USD Exact free cash flow: -39334000 USD 2021-01-01 – 2021-12-31: -38874000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 460000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2021-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -39334000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38874000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017023011396/ttoo-20221231.htm#2153441 Filing: 000095017023011396 Input fundies:CapitalExpenditure: 460000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017023011396/ttoo-20221231.htm#2169735 Filing: 000095017023011396 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 62 million Exact value Exact value: -62003000 USD 2022-01-01 – 2022-12-31: -62003000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2022-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -62003000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62003000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1448615 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	−USD 50.63 million Exact value Exact value: -50629000 USD 2022-01-01 – 2022-12-31: -50629000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2022-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -50629000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50629000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1684705 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	USD 339,000 Exact value Exact value: 339000 USD 2022-01-01 – 2022-12-31: 339000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2022-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 339000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 339000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1692296 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	−USD 50.97 million Calculation and evidence -50629000 − 339000 USD Exact free cash flow: -50968000 USD 2022-01-01 – 2022-12-31: -50629000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 339000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2022-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -50968000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50629000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1684705 Filing: 000095017024039310 Input fundies:CapitalExpenditure: 339000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1692296 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 50.08 million Exact value Exact value: -50077000 USD 2023-01-01 – 2023-12-31: -50077000 USD Inspect Net Income Open source Share or cite Citation for Net Income · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Net Income: -50077000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50077000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1604254 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	−USD 48.14 million Exact value Exact value: -48136000 USD 2023-01-01 – 2023-12-31: -48136000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Operating Cash Flow: -48136000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48136000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1683400 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	USD 192,000 Exact value Exact value: 192000 USD 2023-01-01 – 2023-12-31: 192000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Capital Expenditure: 192000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 192000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1690899 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.	−USD 48.33 million Calculation and evidence -48136000 − 192000 USD Exact free cash flow: -48328000 USD 2023-01-01 – 2023-12-31: -48136000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 192000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · T2 BIOSYSTEMS, INC. · 2023-12-31 T2 BIOSYSTEMS, INC. (edgar:1492674) Free cash flow: -48328000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1492674?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48136000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1683400 Filing: 000095017024039310 Input fundies:CapitalExpenditure: 192000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1492674/000095017024039310/ttoo-20231231.htm#1690899 Filing: 000095017024039310 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

80 filings · 2,974 latest values · 2,974 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001492674, 1492674, TTOO, edgar:1492674

Also known as T2 BIOSYSTEMS, INC., T2 Biosystems, Inc.

T2 BIOSYSTEMS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation